Literature DB >> 10517136

Affinity NMR.

A Chen1, M J Shapiro.   

Abstract

Because binding ligands are directly detected and identified, the diffusion-based NMR method and NOE pumping approach promise to greatly simplify deconvolution in drug screening. An additional advantage of these techniques is that low-affinity ligands, which might be missed by high-throughput screening, can be detected and could serve as synthetic precursors for higher affinity ligands. The biggest challenge to NMR methodology lies in its sensitivity. Compared with other techniques, such as MS (25), NMR methods for screening mixtures are limited by their relative insensitivity. Because of issues such as solubility, stability, and mass limitation, it is not in general judicious to simply increase the concentration of the mixture. Improvements in hardware and software are necessary to extend the applicability of the affinity NMR method to the screening of larger and more complex mixtures. A boost in sensitivity and screening capacity of NMR technique is possible by the implementation of microcoil (26) and flow probe techniques. An upsurge in the capabilities of mixture analysis could be achieved with a combination of independent and complementary techniques (e.g., HPLC, MS) (27). As a unique, nondestructive, and versatile tool, NMR will continue on its fast track of development in the support of drug discovery.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10517136     DOI: 10.1021/ac9907179

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  6 in total

1.  Determining the optimal size of small molecule mixtures for high throughput NMR screening.

Authors:  Kelly A Mercier; Robert Powers
Journal:  J Biomol NMR       Date:  2005-03       Impact factor: 2.835

2.  Analysis of drug-protein binding by ultrafast affinity chromatography using immobilized human serum albumin.

Authors:  Rangan Mallik; Michelle J Yoo; Chad J Briscoe; David S Hage
Journal:  J Chromatogr A       Date:  2010-02-23       Impact factor: 4.759

3.  Substituents on etoposide that interact with human topoisomerase IIalpha in the binary enzyme-drug complex: contributions to etoposide binding and activity.

Authors:  Ryan P Bender; Michael J Jablonksy; Mohammad Shadid; Ian Romaine; Norma Dunlap; Clemens Anklin; David E Graves; Neil Osheroff
Journal:  Biochemistry       Date:  2008-03-21       Impact factor: 3.162

4.  Topoisomerase II - drug interaction domains: identification of substituents on etoposide that interact with the enzyme.

Authors:  Amy M Wilstermann; Ryan P Bender; Murrell Godfrey; Sungjo Choi; Clemens Anklin; David B Berkowitz; Neil Osheroff; David E Graves
Journal:  Biochemistry       Date:  2007-06-20       Impact factor: 3.162

5.  Hereditary tyrosinemia type I-associated mutations in fumarylacetoacetate hydrolase reduce the enzyme stability and increase its aggregation rate.

Authors:  Iratxe Macias; Ana Laín; Ganeko Bernardo-Seisdedos; David Gil; Esperanza Gonzalez; Juan M Falcon-Perez; Oscar Millet
Journal:  J Biol Chem       Date:  2019-07-12       Impact factor: 5.157

Review 6.  Protein-carbohydrate interactions studied by NMR: from molecular recognition to drug design.

Authors:  Maria del Carmen Fernández-Alonso; Dolores Díaz; Manuel Álvaro Berbis; Filipa Marcelo; Javier Cañada; Jesús Jiménez-Barbero
Journal:  Curr Protein Pept Sci       Date:  2012-12       Impact factor: 3.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.